Pedro Zancanaro

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B

Deep Joshipura, Abdulaziz Alomran, Pedro Zancanaro et al. · Journal of the American Academy of Dermatology · 2018 · 80 citations · Full text

Medicine, Dermatology, Pharmacology +10

Sun-protective behaviors in patients with cutaneous hyperpigmentation: A cross-sectional study

Mayra B.C. Maymone, Hind H. Neamah, Stephen A. Wirya et al. · Journal of the American Academy of Dermatology · 2017 · 47 citations

Medicine, Dermatology, Pathology +16

Response to ustekinumab in three pediatric patients with alopecia areata

Abdullah Aleisa, Yeun Jina Lim, Samantha C. Gordon et al. · Pediatric Dermatology · 2018 · 41 citations

Medicine, Dermatology, Pediatrics +13

Dupilumab as a Treatment for Allergic Contact Dermatitis

Naina Chipalkatti, Nicole Lee, Pedro Zancanaro et al. · Dermatitis · 2018 · 36 citations

Life Sciences, Dermatology, Immunology +14

Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil

Julival Ribeiro, John M. Boyce, Pedro Zancanaro · The Brazilian Journal of Infectious Diseases · 2005 · 29 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17